Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 15/3/2021
SIETES contiene 93212 citas

 
 
 1 a 5 de 5 
Presentar resultados
Seleccionar todas
1.Tiene citas relacionadas Cita con resumen
Inrig JK, Barnhart HX, Reddan D, Patel UD, Sapp S, Califf RM, Singh AK, Szczech LA. Effect of hemoglobin target on progression of kidney disease: a secondary analysis of the CHOIR (Correction of Hemoglobin and Outcomes in Renal Insufficiency) trial. Am J Kidney Dis 2012;60:390-41. [Ref.ID 92942]
2.Tiene citas relacionadas Cita con resumen
Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S, Wolfson M, Reddan D, for the CHOIR Investigators. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 2006;355:2085-98. [Ref.ID 78524]
3. Cita con resumen
Topol EJ, Mark DB, Lincoff AM, Cohen E, Burton J, Kleiman N, Talley D, Sapp S, Booth J, Cabot CF, Anderson KM, Califf RM, for the EPISTENT Investigators. Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial. Lancet 1999;354:2019-24. [Ref.ID 48511]
4.Tiene citas relacionadas
Topol EJ, Lincoff M, Sapp S. Coronary stenting and use of abciximab. Authors' reply. Lancet 1998;352:1312. [Ref.ID 41478]
5.
Pilote L, Califf RM, Sapp S, Miller DP, Mark DB, Weaver WD, Gore JM, Armstrong PW, Ohman EM, Topol EJ, for the GUSTO-1 Investigators. Regional variation across the United States in the management of acute myocardial infarction. N Engl J Med 1995;333:565-72. [Ref.ID 24636]
Seleccionar todas
 
 1 a 5 de 5